Paloma Poza-Guedes
Overview
Explore the profile of Paloma Poza-Guedes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Gonzalez-Perez R, Poza-Guedes P, Pineda F, Castillo M, Matheu V, Mederos-Luis E, et al.
J Invest Dermatol
. 2022 Feb;
142(3 Pt A):721-723.
PMID: 35184800
No abstract available.
22.
Gonzalez-Perez R, Poza-Guedes P, Pineda F, Castillo M, Sanchez-Machin I
Life (Basel)
. 2021 Dec;
11(12).
PMID: 34947948
Atopic dermatitis (AD) endotyping might be important for developing personalized diagnostic and therapeutic strategies to the different phenotypes. The current study investigated the IgE molecular profile to () in a...
23.
Toxic epidermal necrolysis induced by cystic fibrosis transmembrane conductance regulator modulators
Mederos-Luis E, Gonzalez-Perez R, Poza-Guedes P, Alava-Cruz C, Matheu V, Sanchez-Machin I
Contact Dermatitis
. 2021 Nov;
86(3):224-225.
PMID: 34731505
No abstract available.
24.
Poza-Guedes P, Gonzalez-Perez R
Clin Transl Allergy
. 2021 Jul;
11(5):e12039.
PMID: 34262693
Introduction: Every year, 1/10,000 children experiences a food-anaphylactic reaction. Most of these events, including attack-related deaths, may happen during the school hours. In the current study, we assessed the influence...
25.
Barrios Y, Franco A, Sanchez-Machin I, Poza-Guedes P, Gonzalez-Perez R, Matheu V
Vaccines (Basel)
. 2021 Jul;
9(6).
PMID: 34205888
Background: Monitoring cellular immune responses elicited in vaccinated individuals is highly complicated. Methods: 28 individuals participated during the vaccination process with 12 BNT162b2 mRNA (Pfizer) vaccine. Specific anti-RBD IgG using...
26.
Barrios Y, Franco A, Sanchez-Machin I, Poza-Guedes P, Gonzalez-Perez R, Matheu V
Clin Immunol
. 2021 Apr;
226:108730.
PMID: 33865990
Objective: To understand the anti-virus adaptive immune response occurring during SARS-Cov-2 infection is necessary to have methods to investigate cellular and humoral components. The goal of this study has been...
27.
Gonzalez-Perez R, Poza-Guedes P
Allergy
. 2021 Apr;
76(4):1298-1299.
PMID: 33840116
No abstract available.
28.
Barranco R, Alava C, Garcia-Moguel I, Mederos E, Iglesias-Souto J, Poza-Guedes P, et al.
Rheumatology (Oxford)
. 2021 Feb;
60(6):3025-3026.
PMID: 33590849
No abstract available.
29.
Gonzalez-Perez R, Poza-Guedes P, Pineda F, Castillo M
Turk Arch Otorhinolaryngol
. 2020 Nov;
58(3):155-162.
PMID: 33145499
Objective: Airway diseases, including allergic rhinitis, are prompted by specific IgE antibodies against airborne allergens and notably those derived from mites. The presented study focused on the specific IgE immediate...
30.
Perez-Garcia J, Hernandez-Perez J, Gonzalez-Perez R, Sardon O, Martin-Gonzalez E, Espuela-Ortiz A, et al.
J Pers Med
. 2020 Sep;
10(3).
PMID: 32933076
Asthma exacerbations are a major contributor to the global disease burden, but no significant predictive biomarkers are known. The Genomics and Metagenomics of Asthma Severity (GEMAS) study aims to assess...